A marketing job at a company whose products live or die on trust, sold to buyers who read the footnotes. Here is what that work looks like from the inside.
Most marketing tries to make you feel something. The kind Thomas Hart works in has to survive a radiologist reading the fine print. He is a Chief Marketing Officer at Siemens Healthineers, the German company whose scanners, lab systems and cancer-care platforms sit in hospitals across much of the world. His office is in Sacramento, a long way from the Bavarian town where the machines are engineered. The distance is the job.
Here is the awkward truth about selling medical technology: the customer has heard every pitch. A hospital buyer, a radiologist, a health-system CFO - these are people trained across whole careers to distrust a confident claim. They read footnotes for a living. A slogan that outruns the evidence does not just fail with them. It costs you the room.
So the work bends away from advertising and toward something harder. Take a genuinely complex idea - an algorithm that flags a finding a tired human might miss, a computable model of an organ, a therapy tuned to one patient's biology - and make it legible to a board that has to spend real money and answer for real outcomes. Less shine, more proof. It is the opposite of hype, done in front of people who will catch you if you are wrong.
To understand the marketing you have to understand the bet behind it. Siemens Healthineers has organized its strategy around three capabilities it keeps returning to in its own public materials: patient twinning, precision therapy, and the trio of digital, data and artificial intelligence. Each one is a promise to reduce doubt - to know more before you cut, dose or decide.
A computable model of the body - or a single organ - used to test decisions before they reach the patient.
Treatment tuned to the individual, folding imaging and cancer care into one workflow.
Software that reads scans, flags findings and moves the routine work off the human.
None of these sell themselves. A digital twin sounds like science fiction until a clinician sees the data behind it. AI in radiology is real and working, yet convincing a hospital to change how it actually operates is a different and slower battle than shipping the algorithm. That gap - between what is remarkable and what a health system will adopt - is where a marketer in this field earns the title.
It helps to picture the scale Hart is marketing inside of. This is not a startup finding its first ten customers. It is one of the oldest names in modern technology, with a workforce and a footprint that make every message a matter of coordination as much as creativity.
A company this size does not get to improvise its voice. When the product touches diagnosis, the tone has to be steady, the claims defensible, the enthusiasm earned. Marketing here is closer to translation and diplomacy than to the loud, fast work the word usually conjures.
There is a reason the quiet playbook works better here than anywhere else. When your audience audits every sentence, exaggeration is not a growth tactic - it is a liability that compounds. The team that overpromises once gets read more skeptically forever. So the incentive runs toward honesty, and the best marketing becomes almost invisible: it just told a clinician something true and useful, and got out of the way.
There is something fitting about the geography of this role. The engineering happens in Forchheim, a Bavarian town better known for its beer cellars than its imaging labs. The marketing sits in Sacramento. In between runs a long supply chain that ends not with a shipped box but with a purchase decision inside an American hospital - and, eventually, a patient on a table. Hart works the seam between those two ends: engineering that is genuinely impressive, and buyers who have heard it all.
That seam is where the honest version of this job lives. It is not about inventing excitement. The excitement is already in the technology. It is about making that technology understandable without making it dishonest, so that a clinician can trust it enough to change how they work. Do that well and nobody notices the marketing at all. Which, in this corner of the business, is the highest compliment there is.
Public records of the individual are thin - a title, a company, a city. But the shape of the work is legible from the outside, because the constraints of the field are so clear. Market to skeptics. Respect what they already know. Let the evidence do the persuading. It is a narrow set of rules, and inside them, a real craft.